STACIE HILL: Open Payments
NPI 1427084714 · FORT GRATIOT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$882 in 51 payments from 13 companies in 2025. Trend: 2023 $759 · 2024 $1,120 · 2025 $882
Food & beverage: $882
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $215 |
| Lilly USA, LLC | 11 | $142 |
| Novo Nordisk Inc | 7 | $120 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
| Axsome Therapeutics, Inc. | 3 | $52 |
| ABBVIE INC. | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
Products named: AIRSUPRA, MOUNJARO, Wegovy, XIFAXAN, CAPLYTA, Auvelity, VRAYLAR, REXULTI.
Industry payments across MI — which companies pay providers there.
